Free Trial
NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

iShares U.S. Pharmaceuticals ETF logo
$66.55 -0.04 (-0.06%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Key Stats

Today's Range
$66.30
$66.63
50-Day Range
$62.06
$68.14
52-Week Range
$58.97
$73.28
Volume
9,465 shs
Average Volume
69,562 shs
Market Capitalization
$562.34 million
Assets Under Management
$559.14 million
Dividend Yield
1.74%
Net Expense Ratio
0.39%
Aggregate Rating
Moderate Buy

ETF Overview

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.39%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.39%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.39%0.60%0.63%0.58%0.60%
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

IHE ETF News Headlines

IHE: Healthcare Dashboard For June
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
IHE Contraction Is Not Justified By Fundamental Data
See More Headlines

IHE ETF - Frequently Asked Questions

iShares U.S. Pharmaceuticals ETF's stock was trading at $65.72 at the beginning of the year. Since then, IHE shares have increased by 1.3% and is now trading at $66.59.
View the best growth stocks for 2025 here
.

iShares U.S. Pharmaceuticals ETF's stock split on the morning of Thursday, March 7th 2024.The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were issued to shareholders after the market closes on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Adobe (ADBE), Lam Research (LRCX) and Advanced Micro Devices (AMD).

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
40

Fund Statistics

Assets Under Management
$555.77 million
Average Daily Volume
$69.35 thousand
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
2
Put Options
1
Call Options
1
Short Interest
507,100 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$306.00
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 IHE Holdings

IHE Sector Exposure

IHE Industry Exposure


This page (NYSEARCA:IHE) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners